A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease

Published:2017-11-14 Issue:3 Volume:12 Page:298-305
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Mogensen Ditte V¹,Brynskov Jørn¹,Ainsworth Mark A¹,Nersting Jacob²,Schmiegelow Kjeld²³,Steenholdt Casper¹

Affiliation:

1. Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark

2. Paediatric Oncology Research Laboratory, Rigshospitalet, University Hospital of Copenhagen, Denmark

3. Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark

Funder

Danish Colitis and Crohn’s Disease Society

Jacob Madsen and Olga Madsens Fund

Herlev-Gentofte Hospital Research Council

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/3/298/27097363/jjx149.pdf

Reference27 articles.

1. Management of Crohn’s disease in adults;Lichtenstein;Am J Gastroenterol,2009

2. Loss of response and requirement of infliximab dose intensification in Crohn’s disease: a review;Gisbert;Am J Gastroenterol,2009

3. Optimizing treatment with TNF inhibitors in inflammatory bowel disease by monitoring drug levels and antidrug antibodies;Steenholdt;Inflamm Bowel Dis,2016

4. Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease;Steenholdt;Aliment Pharmacol Ther,2011

5. Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD;Frederiksen;Inflamm Bowel Dis,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy;Internal Medicine Journal;2024-09-05

2. Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy;Biochemical Pharmacology;2024-08

3. Comparison of Endoscopic Healing and Durability between Combination Therapy with Infliximab and Azathioprine versus Infliximab Monotherapy in Pediatric Crohn's disease;2024-06-25

4. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21

5. Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease;Journal of Gastroenterology and Hepatology;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3